Impact Evaluation of the Nigeria Result-Based Financing Project

March 22, 2019 updated by: World Bank

Impact Evaluation of the Nigeria State Health Program Investment Credit (NSHPIC)

The World Bank and the government of Nigeria are implementing a results-based financing (RBF) project for the states of Nasarawa, Adamawa, and Ondo. This project provides incentives for improving performance at critical levels within the Nigerian health system and aims to address some of these challenges. The primary goal of the impact evaluation of this project is to determine if providing financial incentives linked directly to performance increases the quantity and quality of maternal and child health (MCH) services.

In each of the three selected States,the project finances the following interventions:

  1. Performance incentives to State Government and Local Government (LGA) agencies that are triggered by Disbursement Linked Indicators (DLIs) that reflect strengthened supervision and enhanced operational support for improving health systems performance. These performance incentives would be paid out on an annual basis.
  2. In half of the LGAs in each state, one facility per ward will receive Performance-Based Financing (PBF) wherein payments are made directly to individual health facilities based on the quantity and quality of a set of pre-defined services provided by each facility. These performance incentives would be paid out on a quarterly basis.
  3. In the other half of the LGAs in each state one facility per ward will receive Decentralized Facility Financing (DFF) or equivalent financing that is not be linked to any service delivery targets. These payments would be made on a quarterly basis.

The evaluation of the PBF arm, which consists of making payments to health facilities conditional on performance, but within an environment of comparable levels of overall financing, will rely on experimental assignment. The effect of the PBF intervention will be identified by comparing outcomes in the LGAs receiving PBF versus those receiving DFF in the three project states. In each of these three States, the LGAs will be randomly assigned to either the PBF package or to the DFF package.

Study Overview

Detailed Description

A detailed description can be found in the attached project concept note.

Study Type

Interventional

Enrollment (Actual)

74

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. All health facility staff in the states of Nasarawa, Adamawa and Ondo attending to maternity patients in the study period.
  2. Selected mothers recently utilizing the same facilities if consent is provided.

Exclusion Criteria:

1. None.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: HEALTH_SERVICES_RESEARCH
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Performance-Based Financing
At least one primary healthcare centre per ward and one General Hospital per selected LGA (in 50% of LGAs in each of the 3 states) and one secondary hospital per State will be contracted by the State Primary Health Care Development Agency ) , to deliver specified services at an agreed price. Selection of which services to focus on is based on priorities identified by the Federal Government of Nigeria and the states in 2010-2015. Initial prices for each service were based on shadow prices of providing the service and have been adjusted based on implementation experience.
Incentive-based payments
EXPERIMENTAL: Decentralized Facility Financing
In the other half of the LGA's in each treated state, at least one facility per ward will receive Decentralized Facility Financing (DFF) or equivalent financing that is not be linked to any service delivery targets. These payments would be made on a quarterly basis.
Financing not linked to service delivery.
NO_INTERVENTION: Control
This is a pure control arm with no additional interventions.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Utilization of priority maternal and child health services
Time Frame: Each health facility assessed over a period of two days.
The utilization of priority MCH services, as defined by the quantitative checklist used by the project to measure and reward facility performance.
Each health facility assessed over a period of two days.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Utilization of priority maternal and child health services, particularly by the poor
Time Frame: Each health facility assessed over a period of two days.
The utilization of priority MCH services, as defined by the quantitative checklist used by the project to measure and reward facility performance, by poor households.
Each health facility assessed over a period of two days.
Aggregated Provider Performance through Direct Clinical Observation
Time Frame: Each health provider assessed over a period of one day.
We use data on direct clinical observations of labor and delivery to construct an aggregate measure of provider performance.
Each health provider assessed over a period of one day.
Aggregate Structural and Process Quality Index
Time Frame: Each health facility assessed over a period of two days.
The quantitative checklist used in the government program is replicated to a large degree in the impact evaluation survey. We construct independent observations on aggregate structural and process quality measures in the same fashion as the program has constructed and rewarded.
Each health facility assessed over a period of two days.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Eeshani Kandpal, PhD, World Bank

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

August 20, 2013

Primary Completion (ACTUAL)

September 30, 2017

Study Completion (ANTICIPATED)

December 15, 2019

Study Registration Dates

First Submitted

May 8, 2017

First Submitted That Met QC Criteria

March 22, 2019

First Posted (ACTUAL)

March 26, 2019

Study Record Updates

Last Update Posted (ACTUAL)

March 26, 2019

Last Update Submitted That Met QC Criteria

March 22, 2019

Last Verified

March 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • P128175

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Maternal Care Patterns

Clinical Trials on Performance-Based Financing

3
Subscribe